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APPENDIX VII
THE IMPLANT TEST
E. LONGSTAFF
THE INDUCTION of sarcomas following
s.c. implantation of solid materials has
been widely studied. Bischoff and Bryson
(1964) have published a comprehensive
review of the experimental work in this
field, and have stressed the importance for
sarcoma production of the size and shape
of the implant, as well as the type of
tissue developing around it. When films of
a sufficient size (about 2 cm2) were
implanted, a high incidence of sarcomas
were induced irrespective of the chemical
composition of the test compound. If the
same material was implanted in the form of
perforated films, or in discs about 05 cm
in diameter, fewer tumours were induced,
while the powdered form of the material
was completely inert. Furthermore, it was
shown that the shape ofthe implant was of
major importance in determining tomour
induction. Whensiliconerubber "'buttons",
dumb-bell-shaped in cross section, were
implanted s.c. the number of tumours
induced was much greater than when
plain films of the same material were
employed.
In the study of the s.c. implantation of
discs of petroleum wax in mice, Shubik
et al. (1962) used 5 waxes, ranging in
melting point from 55*3 to 85-3°C. The
tumour incidence around these implants
was low with the 2 lower-melting-point
waxes and much higher with the others.
At necropsy, the low-melting-point waxes
were found to have softened and assumed
the shape of the body at that site, while
the others had remained rigid. No tumours
resulted when a wax that, in disc form,
produced a high yield of tumours, was
implanted in powdered form.
Shulman et al. (1963) implanted strips of
polyethylene mesh and plain polyethylene
film s.c. into rats, and found a higher
incidence of animals with tumours in the
latter group.
Foreign-body tumorigenesis has been
studied by s.c. implantation of Millipore
filters (Karp et al., 1973). There was an
inverse relationship between pore size and
tumour incidence which led to the hypo-
thesis that impairment of cellular contact
or communication caused the tumori-
genicity of the filters with smaller pore
sizes.
Studies of the tissue reaction taking
place around implanted solids have shown
that formation of a thick connective-
tissue capsule invariably precedes tumour
formation by several months, and is an
essential step in the evolution of malig-
nancy. Further, evidence oftheimportance
of the capsule formation in the production
of tumours was provided by the demon-
stration that, once the connective-tissue
capsule was fully established, aseptic
surgical removal of the implant did not
affect the outcome (Oppenheimer et al.,
1958). It is not suirprising, therefore, that
an explaniation for the evolution of
malignancy around solid implants has
been sought in the character of the tissue
reaction (Oppenheimer et al., 1959; Alex-
ander and Horning 1959; Vasiliev et al.,
1962).
The present report describes a novel
techniquewherebythe histological changes
visible after the s.c. implantation of
filter discs containing the test materials are
used to predict carcinogenic potential.
MATERIALS AND METHODS
Implants. Millipore filters (Millipore U.K.
Ltd, type GSWP 01300) ith physical
properties considered to be non-tumorigenic
(i.e. 13 mm diameter, pore size 0-22 ,um and
flexible at body temperature) were used as a
base for the implants. A base was considered
necessary for 2 reasons; (a) to facilitate
surgical implantations by providing a strong
base for the implant, and (b) to enable a
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precise localization of the implant area at
necropsy and subsequent histopathological
appraisal.
The implants were prepared as followA's:
1 ml DMSO containing 1 mmol of the test
substance was suspended in 10 ml of molten
16% wr/v aqueous porcine gelatin (Sigma
(London) Chemical Co.). Molten suspension
(0-2 ml) was then applied to the Millipore
filters, laid on PTFE-coated surfaces and
allowed to gel at room temperature. Each
implant thus contained 0-02 mmol of carcino-
gen. (With some compounds this concentra-
tion proved fatal to the recipients and the
experiments were then repeated at lower
doses.) Control implants contained DMSO but
no added test material.
Implantation.-The discs were implanted
s.e. into the dorso-lumbar region of 2-month-
old Alderley Park Swiss mice under barbitu-
rate anaesthesia. The incision was closed with
silk and dusted with antibiotic powder
(Calmic Medical Division, The Wellcome
Foundation Ltd, Berkhamsted).
At least 20 animals, 10 of each sex, were
used per test compound.
The animals were examined at daily
intervals and killed if in poor clinical condi-
tion.
Necropsy. 3 months after implantation
the surviving mice were killed and the skin
and implant site tissue removed. The exact
implantation site was readily located by the
filter disc.
The skin and adjoining implant site w%as
pinned tissue uppermost in trays of wax
flooded with Bouin's fixative. After embedd-
ing in paraffin wax sagittal section 5,um
thick N-ere cut and stained with haema-
toxylin and eosin.
Histopathological assessment. The appear-
ance of the tissue surrounding the test
implants was assessed relative to that seen
with control implants. The lesions were
scored according to the following scale:
1-Capsule of several layers of viable
and highly orientated fibroblasts with
relatively small nuclei. No significant
number of macrophages adjacent to filter
and no significant necrosis seen.
2-Connective tissue capsule relatively
thick (i.e. > 10 layers of fibroblasts
adjacent to the filter. No necrosis or
significant numbers of other inflammatory
cells.
3 Fibroblast capsule no longer adjacent
to filter, but separated by at least one layer
of macrophages. Capsule thick and eosino-
philic, frequently with significant areas of
necrosis and/or exudative fluid apparent.
4 Capsule thick and eosinophilic, many
cells apparently proliferating. Some areas
of necrosis, fibroblasts or macrophages
wAith large, pale nuclei tending to form foci
writh high mitotic incidence, suggesting
early tumours in situ.
5-Malignant tumour at the site of
irnplant, with cells infiltrating and re-
placing surrounding tissue.
Assessment of group data.-Each section,
was scored using the above criteria. The
mean result from each test compound was
calculated. A positive response wias recorded
when an increase of more than 50%o in the
mean score occurred, or a tumour appeared
at the site of implant. If no filter wAas visible,
the section scored zero, unless a tumour was
diagnosed, but this zero score was not used in
the subsequent determination of the mean
score. In 5 cases when few filters wAere
identified an estimate of the mean score was
made based on available material.
RESULTS
Results of tests on individual com-
pounds are recorded in Table VII.1. It
was not always possible to repeat experi-
ments when the initial trial at the standard
dose proved lethal or toxic to the test
animals, because of limited availability of
some compounds. These events are re-
corded in Table VII.I by the notation
"NT". The carcinogenic potential of
76/111 (68%) compounds was correctly
predicted. Only 19 of the 52 carcinogens
(3700) were positively identified. How-
ever, there were only 2 false-positive
results among the 59 true negatives
tested (i.e. a 3% false-positive rate).
DISCUSSION
A novel technique has been developed
forthe assessment of carcinogenic potential
of organic chemicals by s.c. implantation
in mice. The method was evolved on the
assumption that there were advantages
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TABLE VII.1.-Response to Implanted Test Compounds as % Change in Mean Score,
Relative to Controls.
Prediction
from
Compound % Change Test result literature
Acridine 3
2-Acetylaminofluorene 17 +
4-Acetylaminofluorene NT NT
Aflatoxin B -1
4-Aminoazobenzene -3 +
2-Aminobiphenyl 6 +
4-Aminobiphenyl 60 ± ±
2-Aminochrysene 53 + ± +
6-Aminochrysene 108 ± +
3-Aminopyrene 66 ± +
2-Aminonaphthalene-1-sulphonic acid -16
Aniline -14
p-Anisidine -25
Anthracene -1 -
2-Aminoanthracene 23 - +
Anthranilic acid 6 -
Anthraquinone 43 -
Anthrone 7 -
1,2-Benzanthracene 10 - ±
Benzanthrone 21 -
Benzidine 6 - +
Benzimidazole 46 -
Benzoic acid 1 -
3,4-Benzpyrene 200 ++ +
6-Benzoyl-2-naphthol 39
Biphenyl 15
Bis azo compound 30
Bis(Chloromethyl)ether 95* + +
N,N'-Bis(2-naphthyl)-p-phenylenediamine 95 -
Butanesultone NT NT NT
Caffeine 14
Calmagite 22
Camphor 44
Carbazole -1
Chlorambucil NT NT +
Chloramine T 38
Cholesterol 25
Colchicine NT NT
Croton oil 95* + +
Cyanocobalamin (B12) 11
Cycasin acetate -10 +
Cyclohexylamine 30
Cyclophosphamide 62 + ±
3,3'-Diaminobenzidine 34
2,7-Diaminofluorene 81 ± ±
3,4,5,6-Dibenzacridine -14 -
1,2,3,4-Dibenzanthracene 75 ++ ±
3,4,9,10-Dibenzpyrene 149 ++ ±
3,3'-Dichlorobenzidine 17 - +
2,4-Dichlorophenoxyacetate 11 -
Dicyclohexylamine -10 - -
D.D.T. -5 -
Dieldrin -7 - -
Diethylnitrosamine 40 - ±
Diethylstilboestrol 8 - ±
3,3'-Dimethoxybenzidine 3 - +
4-Dimethylaminoazobenzene 76 + ±
9,10-Dimethylanthracene 51 + ±
p-Dimethylaminobenzaldehyde 5
7,9-Dimethylbenzacridine NT NT +
7,10-Dimethylbenzacridine NT NT ±
9,10-Dimethyl-1,2-benzanthracene 194 ++ +
1,1'-Dimethyl-4,4'-bipyridinium dichloride 7SIX TESTS FOR CARCINOGENICITY 957
TABLE VII.1-continued.
Prediction
from
Compound % Change Test result literature
3,3'-Dimethylbenzidine 21 ± Dimethylcarbamoyl chloride 50 + ± Dimethylformamide -19 -
Dimethylnitrosamine -10 - ± 2,3-Dimethylquinoxaline 23 -
Dinitrobenzene 14 -
2,4-Dinitrofluorobenzene 25 - ±
2,4-Dinitrophenol -12 -
Dinitrosopentamethylene tetramine 30 -
DL-Ethionine 33 - ± 1,1'-Ethylene-2,2'-bipyridinium dibromide 25 -
Ethylenethiourea -3 - ± Ethyl methanesulphonate 7 - + Hexachlorocyclohexane -7 -
Hexamethylphosphoramide 13 - ±
Hydrazine 1 - ± Hydrocortisone 1 -
Indole 2 -
Merchlorethamine 23 - ±
20-Methylcholanthrene 119 ± ± + Methylene bis(2-chloroaniline) 1 - + 2-Methylindole -3 -
MNNG 8 - ±
3-Methyl-4-nitroquinoline-N-oxide 0* -
Mitomycin C -14 - ±
Morgan's base NT NT + Naphthalene 22 -
I-Naphthol 4 -
2-Naphthol -19
I-Naphthylamine 8 -
2-Naphthylamine 14 - + 2-Naphthylamine disulphonic acid 34 -
Nitrobenzene -16 -
2-Nitrobiphenyl NT NT ±
4-Nitrobiphenyl -10 -
2-Nitrofluorene NT NT + N-Nitrosodiphenylamine 14
N-Nitrosoephedrine 22 + N-Nitrosofolic acid 7
4-Nitroquinoline-N-oxide 95* ± ± 4-Nonylphenol/ethylene oxide condensate 0* - -
Orotic acid 3 - -
Perylene 14 -
Phenobarbital 14
N-phenyl-2-naphthylamine 8 - -
Propanesultone 84 ± ±
P-Propiolactone -5 - + Resorcinol 6 -
Riboflavin -8 -
Safrole -17 - ±
3,3',5,5'-Tetramethylbenzidine 22 -
Toluene -14 -
Toluene-2,4-diisocyanate 51 - 2,4,5-Trichlorophenoxyacetate -21
Trimethylphosphate NT NT ±
Urethane 51 ± ±
Vinyl chloride 16 -
*-Estimated values.
+ +-Tumours identified.
NT-Not adequately tested.9.58 I. F. H. PURCHASE ET AL.
to be gained by including an irritant in
the implant (as a Millipore filter of
specific pore size) and suspending the
test compound in gelatin to induce the
production of proteolytic enzymes. Also
the slow dissolution of the gelatin was
thought to provide for the slow and
continuous release of material into the
surrounding tissues, and the filter would
also serve to localize precisely at necropsy.
the challenged tissues.
The advantage of the test system was
that, on occasions, the end-point of the
experiment was a malignant tumour and
a positive response in this sense could
conceivably be considered as definitive,
regardless of the results in other tests in
identifying potential carcinogens. How-
ever, in our experience, tumours were
only seen with potent polycyclics and
there was no case when a chemical which
produced a tumour in the implant test,
failed to have a positive response in
either the mutation or cell-transformation
tests. Surprisingly, no tumours were ever
seen with water-soluble carcinogens or
with non-carcinogens. If a positive score
was obtained in the test (i.e. a fibrous
capsule developed which was thought to
have tumour-related histopathology) then
there was a good chance that the chemical
under test was a carcinogen, but again
there was no case where a carcinogen was
predicted correctly by the implant test,
which was not also identified as such by
either the mutation or cell-transformation
assays. The great disadvantage of the
implant test was insensitivity on the one
hand and protracted duration of study for
little return on the other. Thus, as far as
using the implant test as a routine test for
identifying new carcinogens is concerned,
one is obliged to conclude that it is
inadequate in its present form. As a
model for the regular production of s.c.
sarcomas and carcinomas, however, the
system shows great promise and has been
used to study the temporal events in
tumour formation. The results of these
investigations into the development and
analysis of this model will form the basis
of further publications.
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APPENDIX VIII
OTHER TESTS
TABLE VIII.1
Test
Transplacental
blastomagenesis
Piperidine
alkylation
Iodine test
Acridine test
No. of compounds
tested
10 carcinogens
10 non-carcinogens
8 carcinogens
9 non-carcinogens
22 carcinogens
55 non-carcinogens
22 carcinogens
55 non-carcinogens
No. of compounds
identified correctly
1
10
7
4
13
53
5
42
In addition to the 6 tests which were
extensively validated, 4 tests were sub-
jected to a preliminary study and found
to be insufficiently accurate or sensitive
to warrant a full evaluation. The tests
were: transplacental blastomagenesis (Di
Paolo et al., 1973), piperidine alkylation
(Epstein et al., 1955), the iodine and the
acridine tests (Szent-Gyorgyi et al., 1960.
1961).
The results obtained from these tests
are given in Table VIII.1.
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